ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,503Medicare Part D Prescriptions Filled, Including Refills

Rank: 31 out of 1802

$667K Total Retail Price of All Prescriptions

Rank: 32 out of 1802

388 Patients Receiving at Least One Drug in Part D
93%Patients 65 Years and Older
62% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Wisconsin
Lower avg

Schedule Two
Controlled Substances

12% of this provider’s 388 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

13% of this provider’s 388 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

1% of this provider’s 11,562 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$53 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

32 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Wisconsin
SIMVASTATIN 662 611 1 1
LEVOTHYROXINE SODIUM 575 536 2 2
DONEPEZIL HCL 537 537 3 26
FUROSEMIDE 472 454 4 5
NAMENDA 413 413 5 34
OMEPRAZOLE 379 356 6 4
DIVALPROEX SODIUM 274 255 7 74
ENALAPRIL MALEATE 272 272 8 40
WARFARIN SODIUM 269 253 9 7
LISINOPRIL 238 205 10 3
MIRTAZAPINE 229 229 11 38
METOPROLOL TARTRATE 223 221 12 9
POTASSIUM CHLORIDE 219 214 13 15
AMLODIPINE BESYLATE 211 199 14 6
HYDROCODONE-ACETAMINOPHEN 209 202 S3 15 10
TRAZODONE HCL 202 188 16 39
METOPROLOL SUCCINATE 190 181 17 13
SERTRALINE HCL 174 168 18 20
RISPERIDONE 174 150 18 64
CARBIDOPA-LEVODOPA 138 138 20 70
RANITIDINE HCL 133 130 21 30
PANTOPRAZOLE SODIUM 129 129 22 44
MELOXICAM 119 108 23 59
CLOPIDOGREL 119 119 23 48
CARVEDILOL 117 97 25 36
METFORMIN HCL 116 83 26 11
POLYETHYLENE GLYCOL 3350 114 106 27 29
ESCITALOPRAM OXALATE 114 112 27 104
GLIMEPIRIDE 107 106 29 42
IBUPROFEN 104 98 30 101
CITALOPRAM HBR 99 87 31 17
TAMSULOSIN HCL 97 79 32 28
QUETIAPINE FUMARATE 96 86 33 54
ALENDRONATE SODIUM 96 96 33 21
PRAVASTATIN SODIUM 95 95 35 19
GABAPENTIN 93 72 36 16
ATENOLOL 93 93 36 12
OXYBUTYNIN CHLORIDE ER 90 90 38 99
ISOSORBIDE MONONITRATE ER 86 86 39 66
NEXIUM 85 61 40 50
FENTANYL 82 79 S2 41 43
HYDROCHLOROTHIAZIDE 82 76 41 8
LIDODERM 77 75 43 92
ALLOPURINOL 71 69 44 24
DIGOXIN 71 57 44 45
PLAVIX 67 64 46 81
TRAMADOL HCL 65 48 47 22
JANUVIA 64 57 48 76
CIPROFLOXACIN HCL 63 60 49 109
BENZTROPINE MESYLATE 62 49 R 50 152
ADVAIR DISKUS 59 50 51 32
ZOLPIDEM TARTRATE 54 52 52 27
DIOVAN 54 41 52 57
ATORVASTATIN CALCIUM 53 40 54 14
OLANZAPINE 52 48 55 112
LANTUS SOLOSTAR 51 30 56 63
ZETIA 50 27 57 79
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 13, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.